Press & Statements Archives

Press & Statements

PRESS STATEMENT: New Report Shows Medicare Spending Increase Driven By Specialty Drug Prices

Jul 22, 2015

PRESS STATEMENT: New Report Shows Medicare Spending Increase Driven By Specialty Drug Prices Read More

PRESS STATEMENT: New Report Shows Hepatitis C Drugs Have Costly Impact on California

Jul 1, 2015

Exorbitant price tags for specialty medications are taking a serious financial toll on state budgets. A new analysis released yesterday from the California Association of Health Plans (CAHP) shows that treating only 10 percent of 175,000 patients in state-funded health care programs with just three hepatitis C medications would cost California roughly $1-2 billion. Read More

PRESS STATEMENT: Survey Finds Early Primary State Voters Looking for Action on Prescription Drug Prices

Jun 23, 2015

A recent study of over 2,500 voters in Iowa, South Carolina and New Hampshire found that prescription drug prices are becoming a hot political issue in these early primary states. The study was conducted by Morning Consult on behalf of the Campaign for Sustainable Rx Pricing. Read More

PRESS STATEMENT: New Kaiser Family Foundation Poll Reinforces Need for Sustainable Drug Pricing

Jun 16, 2015

John Rother, President of the National Coalition on Health Care and Chair of the Campaign for Sustainable Rx Pricing issued the following statement in response to a recent health tracking poll by the Kaiser Family Foundation that found that an overwhelming 76% of Americans blame pharmaceutical companies for the rising cost of medicines. Read More